Covered recipient · General Payments record
ANN IGOE
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$1,261.78
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,054.41 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $467.12 | 13 |
| Acerta Pharma LLC | $150.30 | 3 |
| Janssen Scientific Affairs, LLC | $150.00 | 1 |
| GENZYME CORPORATION | $146.19 | 1 |
| Janssen Biotech, Inc. | $35.54 | 2 |
| SOBI, INC | $26.96 | 1 |
| Lilly USA, LLC | $22.43 | 1 |
| ABBVIE INC. | $21.62 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.26 | 1 |
| UCB, Inc. | $15.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.62 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103964517 | CMS |
| Amgen Inc. | $18.80 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111604792 | CMS |
| Amgen Inc. | $17.34 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117284131 | CMS |
| Amgen Inc. | $7.64 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111604794 | CMS |
| Amgen Inc. | $7.81 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111604796 | CMS |
| Amgen Inc. | $17.27 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111604802 | CMS |
| Amgen Inc. | $125.00 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117284129 | CMS |
| Amgen Inc. | $22.67 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111604798 | CMS |
| Amgen Inc. | $30.38 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117284133 | CMS |
| Amgen Inc. | $8.22 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111604800 | CMS |
| Amgen Inc. | $112.81 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117284135 | CMS |
| Amgen Inc. | $16.34 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111604804 | CMS |
| Amgen Inc. | $34.12 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117284137 | CMS |
| Amgen Inc. | $48.72 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117284139 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.44 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104689700 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.05 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105537509 | CMS |
| AstraZeneca Pharmaceuticals LP | $120.81 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105509318 | CMS |
| GENZYME CORPORATION | $146.19 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139923837 | CMS |
| Janssen Biotech, Inc. | $20.38 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078771876 | CMS |
| Janssen Biotech, Inc. | $15.16 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078771899 | CMS |
| Janssen Scientific Affairs, LLC | $150.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078860883 | CMS |
| Lilly USA, LLC | $22.43 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136043214 | CMS |
| Novartis Pharmaceuticals Corporation | $18.26 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086935613 | CMS |
| SOBI, INC | $26.96 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141416982 | CMS |
| UCB, Inc. | $15.99 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143092775 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.